Your Cart ( 1 Item )

• Efficacy and Safety of a New Once-Daily Topical Ketoconazole 2% Gel in the Treatment of Seborrheic Dermatitis: A Phase III Trial
  July 2006 | Volume 5 | Issue 7 | Original Article | 646 | Copyright © July 2006
  Boni Elewski MD, Mark R. Ling MD PhD, Tania J. Phillips MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs